Administering chemo ups income for non-salaried oncologists

Administering chemo ups income for non-salaried oncologists
Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. 26 in the Journal of Clinical Oncology.

(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. 26 in the Journal of Clinical Oncology.

Jennifer L. Malin, M.D., Ph.D., from the University of California at Los Angeles, and colleagues surveyed 480 U.S. oncologists involved in the care of a population-based cohort of patients with lung or colorectal cancer. The authors sought to measure the effects of prescribing chemotherapy or or making referrals to other cancer specialists, hospice, or on medical oncologists' income.

According to the researchers, most oncologists reported that their incomes would be unaffected. But, physicians in fee-for-service practice and those paid a salary with productivity incentives were significantly more likely to report that their income would increase from administering chemotherapy (odds ratios, 7.05 and 7.52, respectively) or administering growth factors (odds ratios, 5.60 and 6.03, respectively), compared with salaried oncologists.

"A substantial proportion of oncologists who are not paid a fixed salary report that their incomes increase when they administer chemotherapy and growth factors," the authors write.

One author disclosed to the pharmaceutical and health insurance industries.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Few physicians refer patients to cancer clinical trials

Feb 12, 2011

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.

Financial hardship common among colon cancer patients

Mar 13, 2012

(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published ...

Recommended for you

Medical marijuana helpful for cancer-linked symptoms

2 hours ago

(HealthDay)—Cannabis and cannabinoid pharmaceuticals can be helpful for nausea and vomiting, pain, and weight loss associated with cancer, according to research published online Dec. 10 in CA: A Cancer Jo ...

Mutations need help from aging tissue to cause leukemia

6 hours ago

Why are older people at higher risk for developing cancer? Prevailing opinion holds that, over time, your body's cells accumulate DNA damage and that eventually this damage catches up with the body in a way ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.